WallStSmart
BNTX

BioNTech SE

NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY

$101.57
-0.48% today

Updated 2026-04-29

Market cap
$25.69B
P/E ratio
P/S ratio
8.95x
EPS (TTM)
$-5.50
Dividend yield
52W range
$80 – $124
Volume
1.2M

BioNTech SE (BNTX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$61.60M$127.58M$108.60M$482.30M$18.98B$17.31B$3.82B$2.75B$2.76B
Revenue growth (YoY)+107.1%-14.9%+344.1%+3834.6%-8.8%-77.9%-28.0%+0.2%
Cost of revenue$9.32M$13.69M$17.40M$59.30M$2.91B$3.00B$599.80M$541.30M$616.47M
Gross profit$52.28M$113.89M$91.20M$423.00M$16.07B$14.32B$3.22B$2.21B$2.14B
Gross margin84.9%89.3%84.0%87.7%84.7%82.7%84.3%80.3%77.6%
R&D$85.50M$143.07M$226.50M$645.00M$949.20M$1.54B$1.78B$2.25B$2.02B
SG&A$22.89M$24.02M$42.50M$95.60M$276.80M$481.70M$495.00M$531.10M$588.20M
Operating income$-61.28M$-53.85M$-181.50M$-82.40M$15.28B$12.64B$690.40M$-1.31B$-623.87M
Operating margin-99.5%-42.2%-167.1%-17.1%80.5%73.0%18.1%-47.8%-22.6%
EBITDA$-74.70M$-23.96M$-143.80M$-105.10M$15.00B$13.10B$1.38B$-367.10M$-256.17M
EBITDA margin-121.3%-18.8%-132.4%-21.8%79.1%75.7%36.1%-13.3%-9.3%
EBIT$-85.23M$-45.94M$-177.70M$-143.80M$14.93B$12.97B$1.19B$-665.10M$-623.87M
Interest expense$651443.00$1.78M$1.69M$1.86M$5.63M$15.82M$7.76M$13.16M$13.64M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-85.65M$-48.02M$-179.10M$15.20M$10.29B$9.43B$930.30M$-665.30M$-1.09B
Net income growth (YoY)+43.9%-273.0%+108.5%+67613.8%-8.3%-90.1%-171.5%-64.0%
Profit margin-139.1%-37.6%-164.9%3.2%54.2%54.5%24.4%-24.2%-39.6%